It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Interactions of the RNA polymerase II (Pol II) preinitiation complex (PIC) and paused early elongation complexes with the first downstream (+1) nucleosome are thought to be functionally important. However, current methods are limited for investigating these relationships, both for cellular chromatin and the human cytomegalovirus (HCMV) genome. Digestion with human DNA fragmentation factor (DFF) before immunoprecipitation (DFF-ChIP) precisely revealed both similarities and major differences in PICs driven by TBP on the host genome in comparison with PICs driven by TBP or the viral-specific, late initiation factor UL87 on the viral genome. Host PICs and paused Pol II complexes are frequently found in contact with the +1 nucleosome and paused Pol II can also be found in a complex involved in the initial invasion of the +1 nucleosome. In contrast, viral transcription complexes have very limited nucleosomal interactions, reflecting a relative lack of chromatinization of transcriptionally active regions of HCMV genomes.
Here the authors digested chromatin with DNA fragmentation factor (DFF) prior to chromatin immunoprecipitation (DFF-ChIP) to depict transcription complex interactions with neighboring nucleosomes in cells. Applying this method to human cytomegalovirus (HMCV)-infected cells, they find that the viral genome is underchromatinized, leading to fewer transcription complex interactions with nucleosomes.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 The University of Iowa, Department of Biochemistry and Molecular Biology, Iowa City, USA (GRID:grid.214572.7) (ISNI:0000 0004 1936 8294)
2 The University of Iowa, Department of Biochemistry and Molecular Biology, Iowa City, USA (GRID:grid.214572.7) (ISNI:0000 0004 1936 8294); The University of Iowa, Department of Internal Medicine, Iowa City, USA (GRID:grid.214572.7) (ISNI:0000 0004 1936 8294); The University of Iowa, Department of Epidemiology, Iowa City, USA (GRID:grid.214572.7) (ISNI:0000 0004 1936 8294); Veterans Affairs Health Care System, Iowa City, USA (GRID:grid.214572.7)
3 The University of Iowa, Department of Internal Medicine, Iowa City, USA (GRID:grid.214572.7) (ISNI:0000 0004 1936 8294); The University of Iowa, Department of Epidemiology, Iowa City, USA (GRID:grid.214572.7) (ISNI:0000 0004 1936 8294); Veterans Affairs Health Care System, Iowa City, USA (GRID:grid.214572.7)
4 Lerner Research Institute, Cleveland Clinic, Department of Cardiovascular and Metabolic Sciences, Cleveland, USA (GRID:grid.239578.2) (ISNI:0000 0001 0675 4725)